论文部分内容阅读
新生儿缺氧缺血性脑病(HIE)是严重危及新生儿生命且易造成各种后遗症的常见疾病。目前尚无有效的治疗方法。我院从1996年10月～1998年12月应用复方丹参注射液与脑活素治疗新生儿缺氧缺血性脑病32例,取得较满意疗效,报告如下。 1 临床资料 1.1 一般资料:本组观察对象为胎龄满38周之足月新生儿,入院日龄<24小时,均符合1989年济南会议制定的新生儿缺氧缺血性脑病诊断标准。共62例,根据治疗方法不同,随机分为治疗组及对照组。治疗组32例,男20例,女12例,出生1分钟Apgar评分0～3分17例,4～6分15例。对照组30例,其性别、年龄、出生体重及窒息程度等方
Neonatal hypoxic-ischemic encephalopathy (HIE) is a common disease that can seriously affect the life of a newborn and can easily lead to various sequelae. There is currently no effective treatment. Our hospital from October 1996 to December 1998 application of compound Danshen injection and cerebrolysin treatment of neonatal hypoxic-ischemic encephalopathy in 32 cases, to obtain more satisfactory efficacy, the report is as follows. 1 Clinical data 1.1 General information: This group of observational objects for full-term gestational age of 38 weeks of full-term newborns, admission days <24 hours, are in line with the 1989 Jinan meeting developed neonatal hypoxic-ischemic encephalopathy diagnostic criteria. A total of 62 cases, according to different treatment methods were randomly divided into treatment group and control group. The treatment group of 32 patients, 20 males and 12 females, 1 minute of birth Apgar score 0 to 3 in 17 cases, 4 to 6 points in 15 cases. Control group, 30 cases of their gender, age, birth weight and degree of asphyxia